A phase 1, randomized, placebo-controlled, single-and multiple-dose, double-blind study to evaluate the pharmacokinetics and safety of rimegepant orally disintegrating tablets 75 mg in healthy Chinese adults

被引：0
作者：
Li, Y. [1 ]
Bertz, R. [2 ]
Goodrich, R.
机构：
[1] Capital Med Univ, Beijing Shijitan Hosp, Beijing, Peoples R China
[2] Biohaven Pharmaceut, New Haven, CT USA
来源：
HEADACHE | 2022年 / 62卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
LB-P-19
引用
收藏
页码：922 / 922
页数：1
相关论文
共 50 条
  • [21] Safety, tolerability, pharmacokinetics, and food effect of baicalein tablets in healthy Chinese subjects: A single-center, randomized, double-blind, placebo-controlled, single-dose phase I study
    Dong, Ruihua
    Li, Lijun
    Gao, Hongzhi
    Lou, Kun
    Luo, Hongmei
    Hao, Sheng
    Yuan, Jing
    Liu, Zeyuan
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 274
  • [22] Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial
    Liu, Xiaoyan
    Zhang, Rui
    Li, Rong
    Wu, Qiong
    Pan, Chao
    Yu, Xiangqing
    Liu, Yuhui
    Wang, Benjie
    Yu, Shuwen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (12)
  • [23] Randomized, double-blind, placebo-controlled, multiple-dose study of the safety, tolerability and pharmacokinetics of benvitimod, a candidate drug for the treatment of psoriasis
    Zhao, L.
    Chen, X.
    Cai, L.
    Zhang, C.
    Wang, Q.
    Jing, S.
    Chen, G.
    Li, J.
    Zhang, J.
    Fang, Y.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (04) : 418 - 423
  • [24] Results of two Phase 1, Randomized, Double-blind, Placebo-controlled, Studies (Ascending Single-dose and Multiple-dose Studies) to Determine the Safety, Tolerability, and Pharmacokinetics of Orally Administered LX9211 in Healthy Participants
    Bundrant, LuAnn
    Hunt, Thomas L.
    Banks, Phil
    Gopinathan, Suma
    Boehm, Kristi A.
    Kassler-Taub, Kenneth
    Tyle, Praveen
    Wilson, Alan
    Warner, Chris
    Wason, Suman
    CLINICAL THERAPEUTICS, 2021, 43 (06) : 1029 - 1050
  • [25] A Phase I, Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Etelcalcetide Administered Intravenously to Chinese Patients With Chronic Kidney Disease Undergoing Hemodialysis
    Xing, Changying
    Chen, Jing
    Zuo, Li
    Fang, Yi
    Ding, Xiaoqiang
    Ni, Zhaohui
    Kong, Carol
    Shi, Guiling
    Lu, Hong
    Hellawell, Jennifer
    Cheng, Sunfa
    Sohn, Winnie
    CLINICAL THERAPEUTICS, 2021, 43 (11) : 2013 - 2023
  • [26] Topiramate for migraine prevention: a randomized, double-blind, placebo-controlled, multiple-dose study
    Brandes, J
    Neto, W
    Jacobs, D
    Bhattacharaya, S
    CEPHALALGIA, 2003, 23 (07) : 694 - 694
  • [27] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
    Li, Haiyan
    Wei, Yudong
    Yang, Zhenhua
    Zhang, Shuang
    Xu, Xiuxiu
    Shuai, Mengmeng
    Vitse, Olivier
    Wu, Yiwen
    Baccara-Dinet, Marie T.
    Zhang, Yi
    Li, Jianyong
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 489 - 503
  • [28] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
    Haiyan Li
    Yudong Wei
    Zhenhua Yang
    Shuang Zhang
    Xiuxiu Xu
    Mengmeng Shuai
    Olivier Vitse
    Yiwen Wu
    Marie T. Baccara-Dinet
    Yi Zhang
    Jianyong Li
    American Journal of Cardiovascular Drugs, 2020, 20 : 489 - 503
  • [29] Safety, Tolerability, Pharmacokinetics, and Food Effects on TAC-302 in Healthy Participants: Randomized, Double-Blind, Placebo-Controlled, Single-Dose and Multiple-Dose Studies
    Sesoko, Shogo
    Huang, Jinhong
    Okayama, Takashige
    Nishida, Erika
    Miyoshi, Kazuhisa
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (07): : 821 - 832
  • [30] A phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects
    Ermer, James
    Martin, Patrick
    Corcoran, Mary
    Matsuo, Yumiko
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (01) : 16 - 29
12345